Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of ...

ATLANTA, GA—Investigational agents that work by inhibiting apolipoprotein C-III (APOC3) are effective at reducing triglyceride levels, two phase IIb studies show. In Bridge-TIMI 73a, treatment with ...

Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of ...

Medically reviewed by Anisha Shah, MD Key Takeaways High triglycerides increase the risk of heart disease and ...

triglyceride test Elevated triglyceride levels were found to be independently associated with adverse cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Elevated ...

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...

Please provide your email address to receive an email when new articles are posted on . Olezarsen reduced triglycerides and the rate of acute pancreatitis events in patients with severely elevated ...